PD
ACHV icon

Point72 (DIFC)’s Achieve Life Sciences ACHV Stock Holding History

Point72 (DIFC)’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$595 Buy
+189
New +$519 ﹤0.01% 1079

Other funds holding ACHV

PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Point72 (DIFC)'s ACHV Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Achieve Life Sciences (ACHV) in Q3 2025: 189 shares worth $595. The stake represents ﹤0.01% of the portfolio and ranks #1079 among its holdings.

66 funds tracked by Wall St. Rank hold ACHV as of Q3 2025.

  • Point72 (DIFC) held 189 shares of Achieve Life Sciences worth $595 as of Q3 2025.
  • Achieve Life Sciences was a new Point72 (DIFC) position in Q3 2025.
  • Achieve Life Sciences made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1079 holding.
  • 66 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.